Rnip and its application in the method and composition of inhibiting nrarp gene expression

摘要

The invention refers to the rnip molecule and its use in pharmaceutical methods and synthesis to inhibit the expression of nrarp gene. The invention also refers to the use of this RNAP molecule in the treatment and / or prevention of new vascular diseases or disorders related to the increase of nrarp gene expression and / or activity. This eye condition was selected from the age-related macular degeneration (AMD) group.Ischemic retinopathy, diabetic crystalline edemaDiffuse diabetic retinopathy (PDR)Diabetic retinitis (DRI)Diabetic retinoedema (DRE) and retinopathy prematurity (ROP) and their combinations.